• Explore /
  • Poster
  • / A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC).

A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC).

Abstract Poster

Authors

Guru P. Sonpavde

Guru Sonpavde

Department of Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA

Guru Sonpavde , Benjamin Louis Maughan , Xiao X. Wei , Bradley Alexander McGregor , Kerry L. Kilbridge , Richard J. Lee , Evan Yu , Michael Thomas Schweizer , Robert B. Montgomery , Heather H. Cheng , Andrew Caleb Hsieh , Ruemu E. Birhiray , Nashat Y. Gabrail , John J. Nemunaitis , Arash Rezazadeh , Peter J. Van Veldhuizen , Nicholas J. Vogelzang , Christopher Ryan Heery , Petros Grivas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT03628716

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS494)

DOI

10.1200/JCO.2019.37.7_suppl.TPS494

Abstract #

TPS494

Poster Bd #

N4

Abstract Disclosures

Similar Posters

First Author: Arvind Chaudhry

First Author: Christopher J. Hoimes

First Author: Arun Rajan

First Author: Himanshu Nagar